Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

  • Glenwood Goss
  • , Chun Ming Tsai
  • , Frances A. Shepherd
  • , Lyudmila Bazhenova
  • , Jong Seok Lee
  • , Gee Chen Chang
  • , Lucio Crino
  • , Miyako Satouchi
  • , Quincy Chu
  • , Toyoaki Hida
  • , Ji Youn Han
  • , Oscar Juan
  • , Frank Dunphy
  • , Makoto Nishio
  • , Jin Hyoung Kang
  • , Margarita Majem
  • , Helen Mann
  • , Mireille Cantarini
  • , Serban Ghiorghiu
  • , Tetsuya Mitsudomi

Research output: Contribution to journal › Article › peer-review

608 Scopus citations

Fingerprint

Dive into the research topics of 'Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science